Act Capital Management, LLC Aravive, Inc. Transaction History

Act Capital Management, LLC

$72.5 Million
Q3 2022

A detailed history of Act Capital Management, LLC transactions in Aravive, Inc. stock. As of the latest transaction made, Act Capital Management, LLC holds 18,777 shares of ARAV stock, worth $0. This represents 0.02% of its overall portfolio holdings.

Number of Shares

18,777

Previous 18,777 -0.0%

Holding current value

Previous $19,000 21.05%

% of portfolio

0.02%

Previous 0.03%

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$0.93 - $1.9 $1,187 - $2,426	1,277 Added 7.3%	18,777 $19,000
Q1 2022 May 11, 2022	BUY	$1.85 - $2.75 $13,875 - $20,625	7,500 Added 75.0%	17,500 $34,000
Q4 2021 Feb 03, 2022	SELL	$2.19 - $4.07 $29,565 - $54,945	-13,500 Reduced 57.45%	10,000 $22,000
Q2 2021 Aug 16, 2021	BUY	$4.65 - $6.42 $109,275 - $150,870	23,500 New	23,500 $141,000

Others Institutions Holding ARAV

# of Institutions

Shares Held

28.1K

Call Options Held

Put Options Held

Massmutual Trust CO Fsb

9.3K
Shares

$0
0.0% of portfolio

View Full List

About Aravive, Inc.

Ticker ARAV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,518,300
Description
Aravive, Inc., a clinical-stage biopharmaceutical company, develops treatments for life-threatening diseases, including cancer and fibrosis in the United States. Its lead product candidate is batiraxcept, an ultrahigh-affinity, decoy protein that targets the GAS6-AXL signaling pathway, which is in Phase III clinical trial for the treatment of pl...

More about ARAV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Act Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Act Capital Management, LLC with notifications on news.

Account

Act Capital Management, LLC Aravive, Inc. Transaction History